Developer docs
API playgroundTry for free, no card

Search company profiles

Programa COPOLAD III

Full company profile

uuid0047132

Namestring
Programa COPOLAD III
Legal namestring
Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas, F.S.P.
Websiteurl
copolad.eu
Company typeenum
Private
Founded yearint
2011
Descriptiontext

COPOLAD III (Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas) is the third phase of a European Union-funded interregional cooperation program on drug policy, operating from 2021 to late 2025/early 2026. It is managed as a consortium led by the Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas (FIIAPP, headquartered in Madrid, Spain), with the Organización Internacional Ítalo-latinoamericana (IILA) as a co-leader and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ, on behalf of BMZ) as a technical partner focused on alternative development. The program engages national drug agencies, public prosecutor offices, national drug observatories, financial intelligence units, national police forces, and civil society organizations across 42 countries in Latin America, the Caribbean, and the European Union.

COPOLAD III delivers capacity-building services free of charge to all participants, including thematic training courses, webinars, working group facilitation, bilateral technical missions, and annual conferences (e.g., the Brussels EU-CELAC high-level meeting). Its substantive outputs include diagnostic studies, guidelines, and training manuals — for example, a financial investigations manual approved by CFATF/GAFIC heads (March 2025), prosecution guidelines on the environmental impacts of drug trafficking developed with AIAMP (December 2025), and a Spanish-language adaptation of the European Prevention Curriculum (EUPC) delivered with EUDA (July 2024). It operates 14 community-care pilots in high-vulnerability contexts and social innovation labs in Peru, Chile, and Colombia. The program does not develop proprietary software or technology products; its intellectual property is a content library of frameworks, studies, and approved protocols hosted on the copolad.eu portal.

COPOLAD III is 100% funded by the European Commission through a grant agreement administered by FIIAPP, with no commercial revenue, no pricing model, and no equity ownership. The financial benchmark is COPOLAD II (2015–2020), which had a €10 million European Commission budget. The program's official website is scheduled to be frozen in December 2025, indicating the planned conclusion of the current phase without a disclosed successor program.

Short descriptiontext

COPOLAD III is an EU-funded interregional cooperation program, led by Spanish foundation FIIAPP with IILA and GIZ, that delivers free drug policy capacity building, training, and methodological guidance to government agencies across 42 Latin American, Caribbean, and EU countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drug policy cooperation, capacity building programs, technical assistance services, policy training and exchange, interregional development cooperation
Industry2 codes
1Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
CodeBPADANAJPrimaryYes
2Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
CodeHLAJAOAMPrimaryNo
NAICS code2 codes
  • International Affairs92812
  • Public Administration92
SIC code1 code
  • International Affairs9721
Product category
International Development Cooperation (Drug Policy)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1EU Grant Funding
TypeManaged Services
Description

COPOLAD III is 100% funded by the European Commission through a grant agreement. The budget is administered by Spain (FIIAPP) over the program's duration. COPOLAD II (2015–2020) had a budget of 10 million euros. No commercial revenue is generated — all activities (training, technical assistance, studies, exchanges) are provided free of charge to participating countries.

copolad.eu
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

COPOLAD III is a European Union-funded technical cooperation program that strengthens drug policy capacity across 42+ countries in Latin America, the Caribbean, and the EU. It delivers training and exchange programs, diagnostic studies, prosecution and investigation guidelines, working groups, and social innovation labs, with all services provided free of charge to participating government agencies, prosecutor offices, financial intelligence units, and civil society organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 14 community service pilots implemented in Latin America and the Caribbean for drug-affected populations
+4 more records
Product overview1 text field

COPOLAD III is a cooperation program between Latin America, the Caribbean, and the European Union on drug policies, managed by the International and Ibero-American Foundation for Administration and Public Policies (FIIAPP) and IILA. The program offers a portfolio of products and services including: training and exchange programs (Formación e Intercambio) with courses, webinars, and workshops; research publications (Estudios) covering environmental impact, gender perspectives, and policy evaluations; guidelines (Guías) for prosecutors and law enforcement; a knowledge library (Biblioteca); a directory of centers and services; working groups (Grupos de trabajo) on various drug policy topics; and annual meetings (Encuentros COPOLAD). The program also produces specialized publications like the Guide on Financial Investigations and the Environmental Impact study, and runs social innovation labs in select countries. COPOLAD III does not operate as a traditional product company but rather as a technical cooperation program funded by the European Union.

Product and service9 records
1Training and Exchange Program (Formación e Intercambio)
CategoryTraining and Capacity Building Service
Description

A core training and exchange program that delivers courses, webinars, workshops, and capacity building activities for drug policy professionals across Latin America, the Caribbean, and the EU. It is provided free of charge to government institutions and includes specialization courses on precursor chemical control, financial investigations, cryptocurrency analysis, and special investigation techniques.

2Research Studies (Estudios)
CategoryResearch and Publication
Description

Research publications and studies on drug policies covering topics such as environmental impact of drug trafficking, gender perspectives, harm reduction strategies, and policy evaluations for Latin American and Caribbean countries. Available free of charge to government institutions and partner organizations.

3Guidelines and Best Practice Documents (Guías)
CategoryPolicy Guidance Document
Description

Guidelines and best practice documents developed to support prosecutors, law enforcement, and policymakers in addressing drug trafficking, money laundering, human trafficking, and gender-related issues. Provided free of charge to AIAMP member prosecutor offices and other government beneficiaries.

4Guide on Financial Investigations and Analysis of Emerging Money Laundering Risks
CategoryTraining Manual / Publication
Description

A comprehensive training manual covering cryptocurrency misuse and money laundering investigations, formally approved by CFATF/GAFIC Heads of Financial Intelligence Units. Authored by Federico Paesano for COPOLAD III, it targets financial intelligence analysts in the Caribbean region.

5Diagnostic Study on Drug Trafficking and Environmental Impact with Criminal Prosecution Guidelines
CategoryDiagnostic Study / Prosecution Guidelines
Description

A diagnostic study and set of criminal prosecution guidelines developed jointly with AIAMP to support Iberoamerican prosecutors in addressing drug trafficking and related environmental crimes. Approved by the Network of Anti-Drug Prosecutors of Iberoamerica.

6Specialization Courses (Cursos de especialización)
CategorySpecialized Training Service
Description

Advanced training courses on topics including precursor chemical control, financial investigations, cryptocurrency analysis, and special investigation techniques. Delivered to law enforcement, financial intelligence analysts, and prosecutor offices free of charge.

7Social Innovation Labs (Laboratorios de innovación social)
CategorySocial Innovation Program
Description

Social innovation labs operating in Peru, Chile, and Colombia that develop drug policy solutions for community protection, youth alternatives to micro-trafficking, and early warning systems for human rights violations. Targets civil society organizations and indigenous communities in drug-affected territories.

8European Prevention Curriculum (EUPC) Training Program in Spanish
CategoryPrevention Training Program
Description

An online training program adapting the European Prevention Curriculum (EUPC) for the Latin American and Caribbean context, co-organized with EUDA. Aimed at prevention professionals and substance use decision-makers across the region.

9Community Service and Territorialization Guides
CategoryCommunity Service Guidelines
Description

Guides developed by COPOLAD III on community services and territorial approaches to vulnerabilities associated with drug use, supporting 14 community care pilots in high-impact contexts across Latin America and the Caribbean.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierKey Regional PartnerTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

GAFIC collaborated with COPOLAD III to deliver a series of training workshops on Financial Investigations and Emerging Money Laundering Risks (February–March 2024). COPOLAD developed a training manual on cryptocurrency use in money laundering, formally approved by the GAFIC Financial Intelligence Unit heads. GAFIC's 59th Plenary was attended by COPOLAD in Negril, Jamaica.

Strategic tierCore Consortium — Joint LeadershipTypeImplementation/ SI/ Consulting Partner
Description

FIIAPP is the managing entity of the COPOLAD consortium. As a Spanish public foundation, FIIAPP administers the European Commission grant and coordinates the overall program implementation, including administrative management, institutional relations with EU and Latin American/Caribbean governments, and day-to-day operations of COPOLAD activities across all work areas.

Strategic tierCore Consortium — Joint LeadershipTypeImplementation/ SI/ Consulting Partner
Description

IILA is a co-leader of the COPOLAD consortium alongside FIIAPP. As an intergovernmental organization, IILA contributes to the program's strategic direction, particularly in coordinating with Italian and other European institutions, and in facilitating cooperation with Latin American member states on drug policy issues.

Strategic tierCore Consortium — Technical PartnerTypeImplementation/ SI/ Consulting Partner
Description

GIZ operates as a technical partner within the COPOLAD consortium, responsible for the Alternative Development component. On behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ), GIZ organizes dialogue forums and provides expertise on sustainable rural development, environmental conservation, agroforestry, reforestation, and ecotourism as alternatives to illicit crop cultivation. GIZ also conducts technical assistance missions on Development Alternative in protected natural areas.

Strategic tierCollaborating InstitutionTypeStrategic or Co-development Partner
Description

EUDA collaborates with COPOLAD III on prevention training, adapting the European Prevention Curriculum (EUPC) to the Latin American and Caribbean context. EUDA organizes and co-brands webinars and training programs delivered through the COPOLAD platform, contributing technical expertise on evidence-based drug prevention methodologies.

6EMCDDA (European Monitoring Centre for Drugs and Drug Addiction)
Strategic tierCollaborating InstitutionTypeStrategic or Co-development Partner
Description

EMCDDA is a key institutional partner supporting COPOLAD's work on National Drug Observatories. It co-organizes annual observatory meetings, provides methodological guidance on trendspotter research, and facilitates knowledge exchange between European and Latin American/Caribbean drug monitoring systems through the REITOX network.

copolad.eu
7CICAD/OEA (Comisión Interamericana para el Control del Abuso de Drogas / Inter-American Drug Abuse Control Commission)
Strategic tierCollaborating InstitutionTypeStrategic or Co-development Partner
Description

CICAD/OEA is a major institutional partner, providing the Inter-American Observatory on Drugs (OID) as a platform for regional drug monitoring. CICAD co-organizes annual observatory meetings with COPOLAD and supports capacity building for national drug observatories across Latin America and the Caribbean.

copolad.eu
8AIAMP (Asociación Iberoamericana de Ministerios Públicos)
Strategic tierFlagship Thematic PartnerTypeStrategic or Co-development Partner
Description

AIAMP is a flagship strategic partner of COPOLAD III. Through its three specialized networks — REDTRAM (anti-trafficking), RFAI (anti-drug prosecutors), and REG (gender) — AIAMP coordinates regional initiatives on prosecutor training, gender-sensitive criminal justice, human trafficking linked to drug trafficking, undercover agent protocols, and environmental crimes. Joint outputs include approved prosecution guidelines and diagnostic reports.

copolad.eu
Strategic tierFlagship Regional PartnerTypeStrategic or Co-development Partner
Description

CELAC is the primary regional counterpart for the EU-CELAC drug policy dialogue facilitated by COPOLAD. The program serves as the operational mechanism for the EU-CELAC cooperation on drug policies, convening 42 national drug agencies for high-level political dialogue and technical cooperation activities.

Strategic tierKey Regional PartnerTypeStrategic or Co-development Partner
Description

GAFILAT and COPOLAD III combine efforts to strengthen intelligence against drug trafficking and money laundering. GAFILAT represents 18 Latin American countries in financial intelligence coordination. The partnership focuses on training, methodology exchange, and capacity building for financial investigations and asset forfeiture linked to drug crimes.

11UIFE México (Unidad de Inteligencia Financiera de México)
Strategic tierTechnical Contributing PartnerTypeStrategic or Co-development Partner
Description

Mexico's Financial Intelligence Unit contributed expertise to the COPOLAD training program on suspicious transactions and analysis techniques for Latin American and Caribbean financial investigators, supporting capacity building in anti-money laundering linked to drug trafficking.

copolad.eu
Strategic tierTechnical Contributing PartnerTypeStrategic or Co-development Partner
Description

Ecuador's Financial Analysis Unit (UAFE) co-supported the COPOLAD training program on suspicious transactions and financial analysis techniques, contributing to the program's capacity-building efforts for investigators across Latin America and the Caribbean.

13REITOX (Red Europea de Información sobre Drogas y Toxicomanías)
Strategic tierSupporting Technical PartnerTypeStrategic or Co-development Partner
Description

REITOX is the European drug information network coordinated by EMCDDA, involving all EU member states. COPOLAD works in close coordination with REITOX for organizing annual observatory meetings and facilitating methodological exchanges between European and Latin American/Caribbean drug monitoring professionals.

copolad.eu
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1AIAMP (Asociación Iberoamericana de Ministerios Públicos)
TypeDirect peer
Description

Iberoamerican association of public prosecutor offices, including anti-drug, anti-trafficking, and gender networks. Closely comparable in cross-border prosecutor coordination, joint protocols, and training — and COPOLAD III's flagship thematic partner.

TypeBroad incumbent
Description

Global UN entity leading international drug and crime policy. Broader mandate but directly comparable function in drug policy standards, capacity building, and cross-border cooperation, frequently overlapping with COPOLAD's thematic areas.

TypeEmerging player
Description

Latin American FATF-style body coordinating anti-money-laundering efforts across 18 LAC countries. Directly comparable in its FIU training, financial investigation methodology, and cross-border cooperation focus, and an active COPOLAD III partner.

4EUROFRONT
TypeDirect peer
Description

EU-funded cooperation program on integrated border management between the EU, Latin America, and the Caribbean. Shares COPOLAD's EU–LAC cooperation mandate, donor (EU), training/technical assistance model, and consortium delivery structure.

5CICAD (Inter-American Drug Abuse Control Commission)
TypeDirect peer
Description

OAS body responsible for drug policy coordination across the Americas, including the Inter-American Observatory on Drugs. Comparable mandate in hemispheric drug policy coordination and observatory capacity building, and a COPOLAD III partner.

6EL PAcCTO (Europe-Latin America Programme of Assistance against Transnational Organized Crime)
TypeDirect peer
Description

EU-funded cooperation program between the EU and Latin America focused on fighting organized crime, including drug trafficking. Closely comparable model: EU grant funding, multi-country consortium, technical assistance, training, and institutional capacity building.

TypeEmerging player
Description

Caribbean regional body coordinating anti-money-laundering policy and financial intelligence. Directly comparable in financial investigation training, FIU coordination, and Caribbean regional engagement, and an active COPOLAD III partner.

TypeDirect peer
Description

EU agency providing evidence-based drug monitoring, prevention curricula, and capacity building to EU member states. Directly comparable function in drugs policy, prevention training, and observatory work, and an active COPOLAD III collaborating partner.

TypeDirect peer
Description

EU-funded regional cooperation program between the EU and Latin America covering social policy and public administration. Comparable structure: EU grant, consortium implementation, government capacity building, and policy dialogue across LAC countries.

TypeDirect peer
Description

EU-funded cooperation program supporting policy dialogue between the EU and Latin America/Caribbean on economic and social issues. Comparable structure: EU grant, consortium implementation, training, and policy dialogue across LAC and EU member states.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Programa COPOLAD III

International Development Cooperation (Drug Policy)copolad.eu

COPOLAD III is an EU-funded interregional cooperation program, led by Spanish foundation FIIAPP with IILA and GIZ, that delivers free drug policy capacity building, training, and methodological guidance to government agencies across 42 Latin American, Caribbean, and EU countries.

What Programa COPOLAD III does

COPOLAD III (Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas) is the third phase of a European Union-funded interregional cooperation program on drug policy, operating from 2021 to late 2025/early 2026. It is managed as a consortium led by the Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas (FIIAPP, headquartered in Madrid, Spain), with the Organización Internacional Ítalo-latinoamericana (IILA) as a co-leader and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ, on behalf of BMZ) as a technical partner focused on alternative development. The program engages national drug agencies, public prosecutor offices, national drug observatories, financial intelligence units, national police forces, and civil society organizations across 42 countries in Latin America, the Caribbean, and the European Union.

COPOLAD III delivers capacity-building services free of charge to all participants, including thematic training courses, webinars, working group facilitation, bilateral technical missions, and annual conferences (e.g., the Brussels EU-CELAC high-level meeting). Its substantive outputs include diagnostic studies, guidelines, and training manuals — for example, a financial investigations manual approved by CFATF/GAFIC heads (March 2025), prosecution guidelines on the environmental impacts of drug trafficking developed with AIAMP (December 2025), and a Spanish-language adaptation of the European Prevention Curriculum (EUPC) delivered with EUDA (July 2024). It operates 14 community-care pilots in high-vulnerability contexts and social innovation labs in Peru, Chile, and Colombia. The program does not develop proprietary software or technology products; its intellectual property is a content library of frameworks, studies, and approved protocols hosted on the copolad.eu portal.

COPOLAD III is 100% funded by the European Commission through a grant agreement administered by FIIAPP, with no commercial revenue, no pricing model, and no equity ownership. The financial benchmark is COPOLAD II (2015–2020), which had a €10 million European Commission budget. The program's official website is scheduled to be frozen in December 2025, indicating the planned conclusion of the current phase without a disclosed successor program.

Programa COPOLAD III firmographics

Firmographics
Name
Programa COPOLAD III
Legal name
Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas, F.S.P.
Website
https://copolad.eu
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
COPOLAD III is an EU-funded interregional cooperation program, led by Spanish foundation FIIAPP with IILA and GIZ, that delivers free drug policy capacity building, training, and methodological guidance to government agencies across 42 Latin American, Caribbean, and EU countries.
Ownership category
akta.pro rank

Programa COPOLAD III industry classification

Industry
Product category
International Development Cooperation (Drug Policy)
NAICS
International Affairs (92812), Public Administration (92)
SIC
International Affairs (9721)
akta.pro primary industry
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
akta.pro secondary industry
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

  • Drug policy cooperation
  • Capacity building programs
  • Technical assistance services
  • Policy training and exchange
  • Interregional development cooperation

Where Programa COPOLAD III is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Programa COPOLAD III business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. EU Grant Funding: COPOLAD III is 100% funded by the European Commission through a grant agreement. The budget is administered by Spain (FIIAPP) over the program's duration. COPOLAD II (2015–2020) had a budget of 10 million euros. No commercial revenue is generated — all activities (training, technical assistance, studies, exchanges) are provided free of charge to participating countries.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Programa COPOLAD III product offering

Product offering

Core offering

COPOLAD III is a European Union-funded technical cooperation program that strengthens drug policy capacity across 42+ countries in Latin America, the Caribbean, and the EU. It delivers training and exchange programs, diagnostic studies, prosecution and investigation guidelines, working groups, and social innovation labs, with all services provided free of charge to participating government agencies, prosecutor offices, financial intelligence units, and civil society organizations.

Product overview

COPOLAD III is a cooperation program between Latin America, the Caribbean, and the European Union on drug policies, managed by the International and Ibero-American Foundation for Administration and Public Policies (FIIAPP) and IILA. The program offers a portfolio of products and services including: training and exchange programs (Formación e Intercambio) with courses, webinars, and workshops; research publications (Estudios) covering environmental impact, gender perspectives, and policy evaluations; guidelines (Guías) for prosecutors and law enforcement; a knowledge library (Biblioteca); a directory of centers and services; working groups (Grupos de trabajo) on various drug policy topics; and annual meetings (Encuentros COPOLAD). The program also produces specialized publications like the Guide on Financial Investigations and the Environmental Impact study, and runs social innovation labs in select countries. COPOLAD III does not operate as a traditional product company but rather as a technical cooperation program funded by the European Union.

Differentiator

Problem solved

Functional benefit

Products and services

  • Training and Exchange Program (Formación e Intercambio) A core training and exchange program that delivers courses, webinars, workshops, and capacity building activities for drug policy professionals across Latin America, the Caribbean, and the EU. It is provided free of charge to government institutions and includes specialization courses on precursor chemical control, financial investigations, cryptocurrency analysis, and special investigation techniques.
  • Research Studies (Estudios) Research publications and studies on drug policies covering topics such as environmental impact of drug trafficking, gender perspectives, harm reduction strategies, and policy evaluations for Latin American and Caribbean countries. Available free of charge to government institutions and partner organizations.
  • Guidelines and Best Practice Documents (Guías) Guidelines and best practice documents developed to support prosecutors, law enforcement, and policymakers in addressing drug trafficking, money laundering, human trafficking, and gender-related issues. Provided free of charge to AIAMP member prosecutor offices and other government beneficiaries.
  • Guide on Financial Investigations and Analysis of Emerging Money Laundering Risks A comprehensive training manual covering cryptocurrency misuse and money laundering investigations, formally approved by CFATF/GAFIC Heads of Financial Intelligence Units. Authored by Federico Paesano for COPOLAD III, it targets financial intelligence analysts in the Caribbean region.
  • Diagnostic Study on Drug Trafficking and Environmental Impact with Criminal Prosecution Guidelines A diagnostic study and set of criminal prosecution guidelines developed jointly with AIAMP to support Iberoamerican prosecutors in addressing drug trafficking and related environmental crimes. Approved by the Network of Anti-Drug Prosecutors of Iberoamerica.
  • Specialization Courses (Cursos de especialización) Advanced training courses on topics including precursor chemical control, financial investigations, cryptocurrency analysis, and special investigation techniques. Delivered to law enforcement, financial intelligence analysts, and prosecutor offices free of charge.
  • Social Innovation Labs (Laboratorios de innovación social) Social innovation labs operating in Peru, Chile, and Colombia that develop drug policy solutions for community protection, youth alternatives to micro-trafficking, and early warning systems for human rights violations. Targets civil society organizations and indigenous communities in drug-affected territories.
  • European Prevention Curriculum (EUPC) Training Program in Spanish An online training program adapting the European Prevention Curriculum (EUPC) for the Latin American and Caribbean context, co-organized with EUDA. Aimed at prevention professionals and substance use decision-makers across the region.
  • Community Service and Territorialization Guides Guides developed by COPOLAD III on community services and territorial approaches to vulnerabilities associated with drug use, supporting 14 community care pilots in high-impact contexts across Latin America and the Caribbean.

Quantifiable outcome

  • 14 community service pilots implemented in Latin America and the Caribbean for drug-affected populations
  • +4 more outcomes

Companies that use Programa COPOLAD III

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Programa COPOLAD III technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Programa COPOLAD III partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered key regional partner, core consortium — joint leadership, core consortium — technical partner, collaborating institution, flagship thematic partner, flagship regional partner, technical contributing partner and supporting technical partner.

  • GAFIC/CFATF (Grupo de Acción Financiera del Caribe / Caribbean Financial Action Task Force)key regional partnerStrategic or Co-development Partner · 1 February 2024GAFIC collaborated with COPOLAD III to deliver a series of training workshops on Financial Investigations and Emerging Money Laundering Risks (February–March 2024). COPOLAD developed a training manual on cryptocurrency use in money laundering, formally approved by the GAFIC Financial Intelligence Unit heads. GAFIC's 59th Plenary was attended by COPOLAD in Negril, Jamaica.
  • FIIAPP (Fundación Internacional y para Iberoamérica de Administración y Políticas Públicas)core consortium — joint leadershipImplementation/ SI/ Consulting PartnerFIIAPP is the managing entity of the COPOLAD consortium. As a Spanish public foundation, FIIAPP administers the European Commission grant and coordinates the overall program implementation, including administrative management, institutional relations with EU and Latin American/Caribbean governments, and day-to-day operations of COPOLAD activities across all work areas.
  • IILA (Organización Internacional Ítalo-latinoamericana)core consortium — joint leadershipImplementation/ SI/ Consulting PartnerIILA is a co-leader of the COPOLAD consortium alongside FIIAPP. As an intergovernmental organization, IILA contributes to the program's strategic direction, particularly in coordinating with Italian and other European institutions, and in facilitating cooperation with Latin American member states on drug policy issues.
  • GIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH)core consortium — technical partnerImplementation/ SI/ Consulting PartnerGIZ operates as a technical partner within the COPOLAD consortium, responsible for the Alternative Development component. On behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ), GIZ organizes dialogue forums and provides expertise on sustainable rural development, environmental conservation, agroforestry, reforestation, and ecotourism as alternatives to illicit crop cultivation. GIZ also conducts technical assistance missions on Development Alternative in protected natural areas.
  • EUDA (European Union Drugs Agency)collaborating institutionStrategic or Co-development PartnerEUDA collaborates with COPOLAD III on prevention training, adapting the European Prevention Curriculum (EUPC) to the Latin American and Caribbean context. EUDA organizes and co-brands webinars and training programs delivered through the COPOLAD platform, contributing technical expertise on evidence-based drug prevention methodologies.
  • EMCDDA (European Monitoring Centre for Drugs and Drug Addiction)collaborating institutionStrategic or Co-development PartnerEMCDDA is a key institutional partner supporting COPOLAD's work on National Drug Observatories. It co-organizes annual observatory meetings, provides methodological guidance on trendspotter research, and facilitates knowledge exchange between European and Latin American/Caribbean drug monitoring systems through the REITOX network.
  • CICAD/OEA (Comisión Interamericana para el Control del Abuso de Drogas / Inter-American Drug Abuse Control Commission)collaborating institutionStrategic or Co-development PartnerCICAD/OEA is a major institutional partner, providing the Inter-American Observatory on Drugs (OID) as a platform for regional drug monitoring. CICAD co-organizes annual observatory meetings with COPOLAD and supports capacity building for national drug observatories across Latin America and the Caribbean.
  • AIAMP (Asociación Iberoamericana de Ministerios Públicos)flagship thematic partnerStrategic or Co-development PartnerAIAMP is a flagship strategic partner of COPOLAD III. Through its three specialized networks — REDTRAM (anti-trafficking), RFAI (anti-drug prosecutors), and REG (gender) — AIAMP coordinates regional initiatives on prosecutor training, gender-sensitive criminal justice, human trafficking linked to drug trafficking, undercover agent protocols, and environmental crimes. Joint outputs include approved prosecution guidelines and diagnostic reports.
  • CELAC (Comunidad de Estados Latinoamericanos y Caribeños)flagship regional partnerStrategic or Co-development PartnerCELAC is the primary regional counterpart for the EU-CELAC drug policy dialogue facilitated by COPOLAD. The program serves as the operational mechanism for the EU-CELAC cooperation on drug policies, convening 42 national drug agencies for high-level political dialogue and technical cooperation activities.
  • GAFILAT (Grupo de Acción Financiera de Latinoamérica)key regional partnerStrategic or Co-development PartnerGAFILAT and COPOLAD III combine efforts to strengthen intelligence against drug trafficking and money laundering. GAFILAT represents 18 Latin American countries in financial intelligence coordination. The partnership focuses on training, methodology exchange, and capacity building for financial investigations and asset forfeiture linked to drug crimes.
  • UIFE México (Unidad de Inteligencia Financiera de México)technical contributing partnerStrategic or Co-development PartnerMexico's Financial Intelligence Unit contributed expertise to the COPOLAD training program on suspicious transactions and analysis techniques for Latin American and Caribbean financial investigators, supporting capacity building in anti-money laundering linked to drug trafficking.
  • UAFE Ecuador (Unidad de Análisis Financiero y Económico de Ecuador)technical contributing partnerStrategic or Co-development PartnerEcuador's Financial Analysis Unit (UAFE) co-supported the COPOLAD training program on suspicious transactions and financial analysis techniques, contributing to the program's capacity-building efforts for investigators across Latin America and the Caribbean.
  • REITOX (Red Europea de Información sobre Drogas y Toxicomanías)supporting technical partnerStrategic or Co-development PartnerREITOX is the European drug information network coordinated by EMCDDA, involving all EU member states. COPOLAD works in close coordination with REITOX for organizing annual observatory meetings and facilitating methodological exchanges between European and Latin American/Caribbean drug monitoring professionals.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Programa COPOLAD III competitors and assessment

Company assessment

Direct peers

  • AIAMP (Asociación Iberoamericana de Ministerios Públicos): Iberoamerican association of public prosecutor offices, including anti-drug, anti-trafficking, and gender networks. Closely comparable in cross-border prosecutor coordination, joint protocols, and training — and COPOLAD III's flagship thematic partner.
  • EUROFRONT: EU-funded cooperation program on integrated border management between the EU, Latin America, and the Caribbean. Shares COPOLAD's EU–LAC cooperation mandate, donor (EU), training/technical assistance model, and consortium delivery structure.
  • CICAD (Inter-American Drug Abuse Control Commission): OAS body responsible for drug policy coordination across the Americas, including the Inter-American Observatory on Drugs. Comparable mandate in hemispheric drug policy coordination and observatory capacity building, and a COPOLAD III partner.
  • EL PAcCTO (Europe-Latin America Programme of Assistance against Transnational Organized Crime): EU-funded cooperation program between the EU and Latin America focused on fighting organized crime, including drug trafficking. Closely comparable model: EU grant funding, multi-country consortium, technical assistance, training, and institutional capacity building.
  • EUDA (European Union Drugs Agency, formerly EMCDDA): EU agency providing evidence-based drug monitoring, prevention curricula, and capacity building to EU member states. Directly comparable function in drugs policy, prevention training, and observatory work, and an active COPOLAD III collaborating partner.
  • EUROsociAL+: EU-funded regional cooperation program between the EU and Latin America covering social policy and public administration. Comparable structure: EU grant, consortium implementation, government capacity building, and policy dialogue across LAC countries.
  • ADELANTE (EU–LAC Cooperation Programme): EU-funded cooperation program supporting policy dialogue between the EU and Latin America/Caribbean on economic and social issues. Comparable structure: EU grant, consortium implementation, training, and policy dialogue across LAC and EU member states.

Broad incumbents

  • UNODC (United Nations Office on Drugs and Crime): Global UN entity leading international drug and crime policy. Broader mandate but directly comparable function in drug policy standards, capacity building, and cross-border cooperation, frequently overlapping with COPOLAD's thematic areas.

Emerging players

  • GAFILAT (Grupo de Acción Financiera de Latinoamérica): Latin American FATF-style body coordinating anti-money-laundering efforts across 18 LAC countries. Directly comparable in its FIU training, financial investigation methodology, and cross-border cooperation focus, and an active COPOLAD III partner.
  • CFATF / GAFIC (Caribbean Financial Action Task Force): Caribbean regional body coordinating anti-money-laundering policy and financial intelligence. Directly comparable in financial investigation training, FIU coordination, and Caribbean regional engagement, and an active COPOLAD III partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Programa COPOLAD III social profiles

Digital presence

Programa COPOLAD III compliance and trust

Trust signal

Compliance1 record

Programa COPOLAD III financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Programa COPOLAD III leadership team

Management profile

Number of profiles

Profiles4 records

Programa COPOLAD III funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Programa COPOLAD III M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Programa COPOLAD III

What does Programa COPOLAD III do?

COPOLAD III is a European Union-funded technical cooperation program that strengthens drug policy capacity across 42+ countries in Latin America, the Caribbean, and the EU. It delivers training and exchange programs, diagnostic studies, prosecution and investigation guidelines, working groups, and social innovation labs, with all services provided free of charge to participating government agencies, prosecutor offices, financial intelligence units, and civil society organizations.

Is Programa COPOLAD III a public or private company?

Programa COPOLAD III is a private company. It is classified as state government owned and is currently operating.

When was Programa COPOLAD III founded?

Programa COPOLAD III was founded in 2011. It employs 1 to 10 people.

Where is Programa COPOLAD III based?

Programa COPOLAD III is headquartered in Madrid, Spain, in the Europe region.

How does Programa COPOLAD III make money?

One revenue line is on record: EU Grant Funding.

Who are Programa COPOLAD III's main competitors?

Direct peers on record are AIAMP (Asociación Iberoamericana de Ministerios Públicos), EUROFRONT, CICAD (Inter-American Drug Abuse Control Commission), EL PAcCTO (Europe-Latin America Programme of Assistance against Transnational Organized Crime), EUDA (European Union Drugs Agency, formerly EMCDDA), EUROsociAL+ and ADELANTE (EU–LAC Cooperation Programme). UNODC (United Nations Office on Drugs and Crime) is listed as a broad incumbent. Emerging players are GAFILAT (Grupo de Acción Financiera de Latinoamérica) and CFATF / GAFIC (Caribbean Financial Action Task Force).

Does Programa COPOLAD III have an API?

No public API is recorded for Programa COPOLAD III.

What industry is Programa COPOLAD III in?

Programa COPOLAD III's product category is International Development Cooperation (Drug Policy). Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 92812 and its SIC code is 9721.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales